Tremfya (guselkumab)

pCPA File Number: 21013

Negotiation Status:

Concluded without agreement

Indication(s):

Psoriasis, moderate to severe plaque

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

SR0530-000

pCPA Engagement Letter Issued:

2018-10-30

Negotiation Process Concluded:

2019-06-21